APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Home Insulin Delivery (Dosing) Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Home Insulin Delivery (Dosing) Devices Market Analysis and Forecast 2026-2032

Report ID 17442535045 July 2026218 pages

Choose your research edition.

Industry ResearchHome Insulin Delivery (Dosing) Devices Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Insulin Delivery (Dosing) Devices Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Home Insulin Delivery (Dosing) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Insulin Delivery (Dosing) Devices Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Insulin Delivery (Dosing) Devices Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Home Insulin Delivery (Dosing) Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Home Insulin Delivery (Dosing) Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Home Insulin Delivery (Dosing) Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Home Insulin Delivery (Dosing) Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Home Insulin Delivery (Dosing) Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Home Insulin Delivery (Dosing) Devices include Medtronic, Ypsomed Holding, Wockhardt, West Pharma, Valeritas, Tandem Diabetes Care, SOOIL, Sanofi and Roche Holding AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Home Insulin Delivery (Dosing) Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Home Insulin Delivery (Dosing) Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Home Insulin Delivery (Dosing) Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Home Insulin Delivery (Dosing) Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Home Insulin Delivery (Dosing) Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Home Insulin Delivery (Dosing) Devices sales, projected growth trends, production technology, application and end-user industry.

Home Insulin Delivery (Dosing) Devices Segment by Company

Medtronic

Ypsomed Holding

Wockhardt

West Pharma

Valeritas

Tandem Diabetes Care

SOOIL

Sanofi

Roche Holding AG

Owen Mumford

Novo Nordisk

MannKind

Julphar

Insulet Corporation

Eli Lilly and Company

Debiotech

Dance Biopharm

Copernicus

Biocon

Beta Bionics

BD

B. Braun

Home Insulin Delivery (Dosing) Devices Segment by Type

Insulin Pumps

Insulin Pens

Insulin Syringes

Others

Home Insulin Delivery (Dosing) Devices Segment by Application

Online Pharmacy

Retail Pharmacy

Hospitals Pharmacy

Home Insulin Delivery (Dosing) Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Insulin Delivery (Dosing) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Insulin Delivery (Dosing) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Insulin Delivery (Dosing) Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Home Insulin Delivery (Dosing) Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Home Insulin Delivery (Dosing) Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Pumps Major Manufacturers Table 3. Insulin Pens Major Manufacturers Table 4. Insulin Syringes Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Online Pharmacy Major Manufacturers Table 8. Retail Pharmacy Major Manufacturers Table 9. Hospitals Pharmacy Major Manufacturers Table 10. Home Insulin Delivery (Dosing) Devices Industry Trends Table 11. Home Insulin Delivery (Dosing) Devices Industry Drivers Table 12. Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges Table 13. Home Insulin Delivery (Dosing) Devices Industry Restraints Table 14. Global Home Insulin Delivery (Dosing) Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2026) Table 18. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2027-2032) Table 19. Global Home Insulin Delivery (Dosing) Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (k units) Table 21. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032) & (k units) Table 22. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2026) Table 23. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2027-2032) Table 24. Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2021-2026) Table 28. Global Home Insulin Delivery (Dosing) Devices Sales Price (USD/unit) of Manufacturers (2021-2026) Table 29. Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Home Insulin Delivery (Dosing) Devices Manufacturers, Product Type & Application Table 32. Global Home Insulin Delivery (Dosing) Devices Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Home Insulin Delivery (Dosing) Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Home Insulin Delivery (Dosing) Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2026) Table 39. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2027-2032) Table 40. Global Home Insulin Delivery (Dosing) Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 42. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 43. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2026) Table 44. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2027-2032) Table 45. Global Home Insulin Delivery (Dosing) Devices Price by Type (2021-2026) & (USD/unit) Table 46. Global Home Insulin Delivery (Dosing) Devices Price by Type (2027-2032) & (USD/unit) Table 47. Global Home Insulin Delivery (Dosing) Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2026) Table 51. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2027-2032) Table 52. Global Home Insulin Delivery (Dosing) Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 54. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 55. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2026) Table 56. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2027-2032) Table 57. Global Home Insulin Delivery (Dosing) Devices Price by Application (2021-2026) & (USD/unit) Table 58. Global Home Insulin Delivery (Dosing) Devices Price by Application (2027-2032) & (USD/unit) Table 59. Medtronic Company Information Table 60. Medtronic Business Overview Table 61. Medtronic Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 62. Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio Table 63. Medtronic Recent Development Table 64. Ypsomed Holding Company Information Table 65. Ypsomed Holding Business Overview Table 66. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio Table 68. Ypsomed Holding Recent Development Table 69. Wockhardt Company Information Table 70. Wockhardt Business Overview Table 71. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio Table 73. Wockhardt Recent Development Table 74. West Pharma Company Information Table 75. West Pharma Business Overview Table 76. West Pharma Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio Table 78. West Pharma Recent Development Table 79. Valeritas Company Information Table 80. Valeritas Business Overview Table 81. Valeritas Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio Table 83. Valeritas Recent Development Table 84. Tandem Diabetes Care Company Information Table 85. Tandem Diabetes Care Business Overview Table 86. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio Table 88. Tandem Diabetes Care Recent Development Table 89. SOOIL Company Information Table 90. SOOIL Business Overview Table 91. SOOIL Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio Table 93. SOOIL Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio Table 98. Sanofi Recent Development Table 99. Roche Holding AG Company Information Table 100. Roche Holding AG Business Overview Table 101. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio Table 103. Roche Holding AG Recent Development Table 104. Owen Mumford Company Information Table 105. Owen Mumford Business Overview Table 106. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio Table 108. Owen Mumford Recent Development Table 109. Novo Nordisk Company Information Table 110. Novo Nordisk Business Overview Table 111. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio Table 113. Novo Nordisk Recent Development Table 114. MannKind Company Information Table 115. MannKind Business Overview Table 116. MannKind Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio Table 118. MannKind Recent Development Table 119. Julphar Company Information Table 120. Julphar Business Overview Table 121. Julphar Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio Table 123. Julphar Recent Development Table 124. Insulet Corporation Company Information Table 125. Insulet Corporation Business Overview Table 126. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio Table 128. Insulet Corporation Recent Development Table 129. Eli Lilly and Company Company Information Table 130. Eli Lilly and Company Business Overview Table 131. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio Table 133. Eli Lilly and Company Recent Development Table 134. Debiotech Company Information Table 135. Debiotech Business Overview Table 136. Debiotech Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio Table 138. Debiotech Recent Development Table 139. Dance Biopharm Company Information Table 140. Dance Biopharm Business Overview Table 141. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio Table 143. Dance Biopharm Recent Development Table 144. Copernicus Company Information Table 145. Copernicus Business Overview Table 146. Copernicus Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio Table 148. Copernicus Recent Development Table 149. Biocon Company Information Table 150. Biocon Business Overview Table 151. Biocon Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio Table 153. Biocon Recent Development Table 154. Beta Bionics Company Information Table 155. Beta Bionics Business Overview Table 156. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio Table 158. Beta Bionics Recent Development Table 159. BD Company Information Table 160. BD Business Overview Table 161. BD Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. BD Home Insulin Delivery (Dosing) Devices Product Portfolio Table 163. BD Recent Development Table 164. B. Braun Company Information Table 165. B. Braun Business Overview Table 166. B. Braun Home Insulin Delivery (Dosing) Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio Table 168. B. Braun Recent Development Table 169. North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 172. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 173. North America Home Insulin Delivery (Dosing) Devices Sales Price by Type (2021-2026) & (USD/unit) Table 174. North America Home Insulin Delivery (Dosing) Devices Sales Price by Type (2027-2032) & (USD/unit) Table 175. North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 176. North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 177. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 178. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 179. North America Home Insulin Delivery (Dosing) Devices Sales Price by Application (2021-2026) & (USD/unit) Table 180. North America Home Insulin Delivery (Dosing) Devices Sales Price by Application (2027-2032) & (USD/unit) Table 181. North America Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. North America Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. North America Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 185. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 186. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 187. North America Home Insulin Delivery (Dosing) Devices Sales Price by Country (2021-2026) & (USD/unit) Table 188. North America Home Insulin Delivery (Dosing) Devices Sales Price by Country (2027-2032) & (USD/unit) Table 189. United States Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 190. Canada Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 191. Mexico Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 192. Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 193. Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 194. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 195. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 196. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Type (2021-2026) & (USD/unit) Table 197. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Type (2027-2032) & (USD/unit) Table 198. Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 199. Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 200. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 201. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 202. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Application (2021-2026) & (USD/unit) Table 203. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Application (2027-2032) & (USD/unit) Table 204. Europe Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Europe Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Europe Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 209. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 210. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Country (2021-2026) & (USD/unit) Table 211. Europe Home Insulin Delivery (Dosing) Devices Sales Price by Country (2027-2032) & (USD/unit) Table 212. Germany Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 213. France Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 214. U.K. Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 215. Italy Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 216. Russia Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 217. Spain Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 218. Netherlands Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 219. Switzerland Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 220. Sweden Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 221. Poland Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 222. China Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 223. China Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 224. China Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 225. China Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 226. China Home Insulin Delivery (Dosing) Devices Sales Price by Type (2021-2026) & (USD/unit) Table 227. China Home Insulin Delivery (Dosing) Devices Sales Price by Type (2027-2032) & (USD/unit) Table 228. China Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 229. China Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 230. China Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 231. China Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 232. China Home Insulin Delivery (Dosing) Devices Sales Price by Application (2021-2026) & (USD/unit) Table 233. China Home Insulin Delivery (Dosing) Devices Sales Price by Application (2027-2032) & (USD/unit) Table 234. Asia Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 235. Asia Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 236. Asia Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 237. Asia Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 238. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Type (2021-2026) & (USD/unit) Table 239. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Type (2027-2032) & (USD/unit) Table 240. Asia Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 241. Asia Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 242. Asia Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 243. Asia Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 244. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Application (2021-2026) & (USD/unit) Table 245. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Application (2027-2032) & (USD/unit) Table 246. Asia Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. Asia Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. Asia Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. Asia Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 250. Asia Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 251. Asia Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 252. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Country (2021-2026) & (USD/unit) Table 253. Asia Home Insulin Delivery (Dosing) Devices Sales Price by Country (2027-2032) & (USD/unit) Table 254. Japan Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 255. South Korea Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 256. India Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 257. Australia Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 258. Taiwan Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 259. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 260. SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (US$ Million) Table 261. SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (US$ Million) Table 262. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 263. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 264. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Type (2021-2026) & (USD/unit) Table 265. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Type (2027-2032) & (USD/unit) Table 266. SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (US$ Million) Table 267. SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (US$ Million) Table 268. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 269. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 270. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Application (2021-2026) & (USD/unit) Table 271. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Application (2027-2032) & (USD/unit) Table 272. SAMEA Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 273. SAMEA Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 274. SAMEA Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 275. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 276. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 277. SAMEA Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 278. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Country (2021-2026) & (USD/unit) Table 279. SAMEA Home Insulin Delivery (Dosing) Devices Sales Price by Country (2027-2032) & (USD/unit) Table 280. Brazil Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 281. Argentina Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 282. Chile Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 283. Colombia Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 284. Peru Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 285. Saudi Arabia Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 286. Israel Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 287. UAE Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 288. Turkey Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 289. Iran Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 290. Egypt Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Table 291. Key Raw Materials Table 292. Raw Materials Key Suppliers Table 293. Home Insulin Delivery (Dosing) Devices Distributors List Table 294. Home Insulin Delivery (Dosing) Devices Customers List Table 295. Research Programs/Design for This Report Table 296. Authors List of This Report Table 297. Secondary Sources Table 298. Primary Sources List of Figures Figure 1. Home Insulin Delivery (Dosing) Devices Image Figure 2. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Pumps Image Figure 5. Insulin Pens Image Figure 6. Insulin Syringes Image Figure 7. Others Image Figure 8. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Home Insulin Delivery (Dosing) Devices Market Size Share 2021 VS 2025 VS 2032 Figure 10. Online Pharmacy Image Figure 11. Retail Pharmacy Image Figure 12. Hospitals Pharmacy Image Figure 13. Global Home Insulin Delivery (Dosing) Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Figure 15. Global Home Insulin Delivery (Dosing) Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2032) Figure 18. Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032) & (k units) Figure 19. Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Home Insulin Delivery (Dosing) Devices Sales YoY (2021-2032) & (k units) Figure 22. Europe Home Insulin Delivery (Dosing) Devices Sales YoY (2021-2032) & (k units) Figure 23. China Home Insulin Delivery (Dosing) Devices Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Home Insulin Delivery (Dosing) Devices Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales YoY (2021-2032) & (k units) Figure 26. Global Home Insulin Delivery (Dosing) Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Home Insulin Delivery (Dosing) Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032) Figure 32. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032) Figure 35. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032) Figure 38. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032) Figure 41. North America Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2021-2032) Figure 42. North America Home Insulin Delivery (Dosing) Devices Sales Share by Type (2021-2032) Figure 43. North America Home Insulin Delivery (Dosing) Devices Revenue Share by Application (2021-2032) Figure 44. North America Home Insulin Delivery (Dosing) Devices Sales Share by Application (2021-2032) Figure 45. North America Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2021-2032) Figure 46. North America Home Insulin Delivery (Dosing) Devices Sales Share by Country (2021-2032) Figure 47. Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2021-2032) Figure 48. Europe Home Insulin Delivery (Dosing) Devices Sales Share by Type (2021-2032) Figure 49. Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Application (2021-2032) Figure 50. Europe Home Insulin Delivery (Dosing) Devices Sales Share by Application (2021-2032) Figure 51. Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2021-2032) Figure 52. Europe Home Insulin Delivery (Dosing) Devices Sales Share by Country (2021-2032) Figure 53. China Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2021-2032) Figure 54. China Home Insuli

Scope & coverage.

Types
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Others
Applications
  • Online Pharmacy
  • Retail Pharmacy
  • Hospitals Pharmacy
Companies covered
  • Medtronic
  • Ypsomed Holding
  • Wockhardt
  • West Pharma
  • Valeritas
  • Tandem Diabetes Care
  • SOOIL
  • Sanofi
  • Roche Holding AG
  • Owen Mumford
  • Novo Nordisk
  • MannKind
  • Julphar
  • Insulet Corporation
  • Eli Lilly and Company
  • Debiotech
  • Dance Biopharm
  • Copernicus
  • Biocon
  • Beta Bionics
  • BD
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Home Insulin Delivery (Dosing) Devices Market by Type
  3. 1.2.1 Global Home Insulin Delivery (Dosing) Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin Pumps
  5. 1.2.3 Insulin Pens
  6. 1.2.4 Insulin Syringes
  7. 1.2.5 Others
  8. 1.3 Home Insulin Delivery (Dosing) Devices Market by Application
  9. 1.3.1 Global Home Insulin Delivery (Dosing) Devices Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Online Pharmacy
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Hospitals Pharmacy
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Home Insulin Delivery (Dosing) Devices Market Dynamics
  1. 2.1 Home Insulin Delivery (Dosing) Devices Industry Trends
  2. 2.2 Home Insulin Delivery (Dosing) Devices Industry Drivers
  3. 2.3 Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
  4. 2.4 Home Insulin Delivery (Dosing) Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Home Insulin Delivery (Dosing) Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Region
  3. 3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Home Insulin Delivery (Dosing) Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Home Insulin Delivery (Dosing) Devices Sales by Region
  9. 3.4.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers
  2. 4.1.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Home Insulin Delivery (Dosing) Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers
  6. 4.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Home Insulin Delivery (Dosing) Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Home Insulin Delivery (Dosing) Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Home Insulin Delivery (Dosing) Devices Manufacturers, Product Type & Application
  13. 4.7 Global Home Insulin Delivery (Dosing) Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Home Insulin Delivery (Dosing) Devices Market CR5 and HHI
  16. 4.8.2 2025 Home Insulin Delivery (Dosing) Devices Tier 1, Tier 2, and Tier 3
5 Home Insulin Delivery (Dosing) Devices Market by Type
  1. 5.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Type
  2. 5.1.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Home Insulin Delivery (Dosing) Devices Sales by Type
  6. 5.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Home Insulin Delivery (Dosing) Devices Price by Type
6 Home Insulin Delivery (Dosing) Devices Market by Application
  1. 6.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Application
  2. 6.1.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Home Insulin Delivery (Dosing) Devices Sales by Application
  6. 6.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Home Insulin Delivery (Dosing) Devices Price by Application
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Ypsomed Holding
  8. 7.2.1 Ypsomed Holding Company Information
  9. 7.2.2 Ypsomed Holding Business Overview
  10. 7.2.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
  12. 7.2.5 Ypsomed Holding Recent Developments
  13. 7.3 Wockhardt
  14. 7.3.1 Wockhardt Company Information
  15. 7.3.2 Wockhardt Business Overview
  16. 7.3.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
  18. 7.3.5 Wockhardt Recent Developments
  19. 7.4 West Pharma
  20. 7.4.1 West Pharma Company Information
  21. 7.4.2 West Pharma Business Overview
  22. 7.4.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
  24. 7.4.5 West Pharma Recent Developments
  25. 7.5 Valeritas
  26. 7.5.1 Valeritas Company Information
  27. 7.5.2 Valeritas Business Overview
  28. 7.5.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
  30. 7.5.5 Valeritas Recent Developments
  31. 7.6 Tandem Diabetes Care
  32. 7.6.1 Tandem Diabetes Care Company Information
  33. 7.6.2 Tandem Diabetes Care Business Overview
  34. 7.6.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
  36. 7.6.5 Tandem Diabetes Care Recent Developments
  37. 7.7 SOOIL
  38. 7.7.1 SOOIL Company Information
  39. 7.7.2 SOOIL Business Overview
  40. 7.7.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
  42. 7.7.5 SOOIL Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
  49. 7.9 Roche Holding AG
  50. 7.9.1 Roche Holding AG Company Information
  51. 7.9.2 Roche Holding AG Business Overview
  52. 7.9.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
  54. 7.9.5 Roche Holding AG Recent Developments
  55. 7.10 Owen Mumford
  56. 7.10.1 Owen Mumford Company Information
  57. 7.10.2 Owen Mumford Business Overview
  58. 7.10.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
  60. 7.10.5 Owen Mumford Recent Developments
  61. 7.11 Novo Nordisk
  62. 7.11.1 Novo Nordisk Company Information
  63. 7.11.2 Novo Nordisk Business Overview
  64. 7.11.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
  66. 7.11.5 Novo Nordisk Recent Developments
  67. 7.12 MannKind
  68. 7.12.1 MannKind Company Information
  69. 7.12.2 MannKind Business Overview
  70. 7.12.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
  72. 7.12.5 MannKind Recent Developments
  73. 7.13 Julphar
  74. 7.13.1 Julphar Company Information
  75. 7.13.2 Julphar Business Overview
  76. 7.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
  78. 7.13.5 Julphar Recent Developments
  79. 7.14 Insulet Corporation
  80. 7.14.1 Insulet Corporation Company Information
  81. 7.14.2 Insulet Corporation Business Overview
  82. 7.14.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
  84. 7.14.5 Insulet Corporation Recent Developments
  85. 7.15 Eli Lilly and Company
  86. 7.15.1 Eli Lilly and Company Company Information
  87. 7.15.2 Eli Lilly and Company Business Overview
  88. 7.15.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
  90. 7.15.5 Eli Lilly and Company Recent Developments
  91. 7.16 Debiotech
  92. 7.16.1 Debiotech Company Information
  93. 7.16.2 Debiotech Business Overview
  94. 7.16.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
  96. 7.16.5 Debiotech Recent Developments
  97. 7.17 Dance Biopharm
  98. 7.17.1 Dance Biopharm Company Information
  99. 7.17.2 Dance Biopharm Business Overview
  100. 7.17.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
  102. 7.17.5 Dance Biopharm Recent Developments
  103. 7.18 Copernicus
  104. 7.18.1 Copernicus Company Information
  105. 7.18.2 Copernicus Business Overview
  106. 7.18.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
  108. 7.18.5 Copernicus Recent Developments
  109. 7.19 Biocon
  110. 7.19.1 Biocon Company Information
  111. 7.19.2 Biocon Business Overview
  112. 7.19.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
  114. 7.19.5 Biocon Recent Developments
  115. 7.20 Beta Bionics
  116. 7.20.1 Beta Bionics Company Information
  117. 7.20.2 Beta Bionics Business Overview
  118. 7.20.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
  120. 7.20.5 Beta Bionics Recent Developments
  121. 7.21 BD
  122. 7.21.1 BD Company Information
  123. 7.21.2 BD Business Overview
  124. 7.21.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
  126. 7.21.5 BD Recent Developments
  127. 7.22 B. Braun
  128. 7.22.1 B. Braun Company Information
  129. 7.22.2 B. Braun Business Overview
  130. 7.22.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
  132. 7.22.5 B. Braun Recent Developments
8 North America
  1. 8.1 North America Home Insulin Delivery (Dosing) Devices Market Size by Type
  2. 8.1.1 North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
  5. 8.2 North America Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 8.2.1 North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
  9. 8.3 North America Home Insulin Delivery (Dosing) Devices Market Size by Country
  10. 8.3.1 North America Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Home Insulin Delivery (Dosing) Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Home Insulin Delivery (Dosing) Devices Market Size by Type
  2. 9.1.1 Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
  5. 9.2 Europe Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 9.2.1 Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
  9. 9.3 Europe Home Insulin Delivery (Dosing) Devices Market Size by Country
  10. 9.3.1 Europe Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Home Insulin Delivery (Dosing) Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Home Insulin Delivery (Dosing) Devices Market Size by Type
  2. 10.1.1 China Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  4. 10.1.3 China Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
  5. 10.2 China Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 10.2.1 China Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 10.2.3 China Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Home Insulin Delivery (Dosing) Devices Market Size by Type
  2. 11.1.1 Asia Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
  5. 11.2 Asia Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 11.2.1 Asia Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
  9. 11.3 Asia Home Insulin Delivery (Dosing) Devices Market Size by Country
  10. 11.3.1 Asia Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Home Insulin Delivery (Dosing) Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Home Insulin Delivery (Dosing) Devices Market Size by Type
  2. 12.1.1 SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Home Insulin Delivery (Dosing) Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Home Insulin Delivery (Dosing) Devices Market Size by Application
  6. 12.2.1 SAMEA Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Home Insulin Delivery (Dosing) Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Home Insulin Delivery (Dosing) Devices Market Size by Country
  10. 12.3.1 SAMEA Home Insulin Delivery (Dosing) Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Home Insulin Delivery (Dosing) Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Home Insulin Delivery (Dosing) Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Home Insulin Delivery (Dosing) Devices Value Chain Analysis
  2. 13.1.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Home Insulin Delivery (Dosing) Devices Production Mode & Process
  6. 13.2 Home Insulin Delivery (Dosing) Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Home Insulin Delivery (Dosing) Devices Distributors
  9. 13.2.3 Home Insulin Delivery (Dosing) Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst